Simplex Trading
HTGM

Simplex Trading’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Simplex Trading’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Hold
0
– -$1K – 9331
2020
Q3 		– Hold
0
– – – 7631

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Simplex Trading's HTGM Position: Q3 2020 in Review

Simplex Trading sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2020, closing a stake of 3 shares — an estimated $268 sold.

Simplex Trading first reported a position in HTGM in Q2 2018 and held it in 6 quarters. The position peaked at $151K in Q3 2018. 28 funds tracked by Wall St. Rank hold HTGM as of Q3 2020.

  • Simplex Trading reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Simplex Trading sold 3 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2020, an estimated $268.
  • Simplex Trading first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • Simplex Trading's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $151K in Q3 2018.
  • 28 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2020.

Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.